SCHEMBL7790528

SCHEMBL7790528

Cc1ccc(N2CCCC(CO)C2)cc1

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.51
RAB9A P51151 1/20 0.46
KHK P50053 1/20 0.45
ADRB1 P08588 1/20 0.43
PTGER4 P35408 2/20 0.42
MAP4K4 O95819 1/20 0.42
SYK P43405 4/20 0.41
JAK2 O60674 1/20 0.41
TYMP P19971 2/20 0.41
PIK3CA P42336 1/20 0.41
MTOR P42345 1/20 0.41
CYP2D6 P10635 1/20 0.40
PTPN1 P18031 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12045685 0.90 ADRB1 (0.46) EPHX2RAB9AADRB1SYK
SCHEMBL10177559 0.85 ADRB1 (0.41) EPHX2RAB9AADRB1
SCHEMBL25855629 0.85 ESR1 (0.45) KHKMAP4K4SYKJAK2TYMP
SCHEMBL21135496 0.84 NOTUM (0.49) EPHX2ADRB1MAP4K4SYKJAK2
SCHEMBL6271445 0.84 NOTUM (0.49) EPHX2ADRB1MAP4K4SYKJAK2
SCHEMBL21135466 0.84 CYP3A4 (0.56) RAB9AMAP4K4SYKJAK2TYMP
SCHEMBL77035 0.84 KDM4E (0.49) RAB9AKHKMAP4K4SYKJAK2
SCHEMBL21135575 0.84 CYP3A4 (0.56) RAB9AMAP4K4SYKJAK2TYMP
SCHEMBL21135458 0.84 NOTUM (0.49) EPHX2ADRB1MAP4K4SYKJAK2
SCHEMBL7146014 0.84 CYP3A4 (0.56) RAB9AMAP4K4SYKJAK2TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150963-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Aventis Pharma Deutschland GmbH (DE) 2001-11-07 EP disclosed
WO-2000046214-A1 SUBSTITUTED 4-AMINO-2-ARYLTETRAHYDROQUINAZOLINES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-08-10 WO disclosed